McCamish Mark Anthony
SEC insider (Form 3/4/5 filer). CIK 0001390798. Director at AVADEL PHARMACEUTICALS PLC (AVDL). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in DUBLIN 2, L2.
Companies McCamish Mark Anthony has filed insider reports for
- AVADEL PHARMACEUTICALS PLC (AVDL): Director
McCamish Mark Anthony
CIK: 0001390798
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)4 (80.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVDL
AVADEL PHARMACEUTICALS PLC
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 12, 2026AVDL
AVADEL PHARMACEUTICALS PLC
DispositionDirect22K shares at avg. $21.00$462K - Feb 12, 2026AVDL
AVADEL PHARMACEUTICALS PLC
DispositionIndirect67K shares at avg. $21.00$1.4M - Feb 4, 2026AVDL
AVADEL PHARMACEUTICALS PLC
GiftIndirect67K shares- - Feb 4, 2026AVDL
AVADEL PHARMACEUTICALS PLC
GiftIndirect67K shares- - Jul 29, 2025AVDL
AVADEL PHARMACEUTICALS PLC
AwardDirect11K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | Disposition | 22,000 | $21.00 | $462,000 | Direct |
| Feb 12, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | Disposition | 67,025 | $21.00 | $1,407,525 | Indirect |
| Feb 4, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | Gift | 67,025 | - | $0 | Indirect |
| Feb 4, 2026 | AVDL AVADEL PHARMACEUTICALS PLC | Gift | 67,025 | - | $0 | Indirect |
| Jul 29, 2025 | AVDL AVADEL PHARMACEUTICALS PLC | Award | 11,000 | - | - | Direct |
1-5 of 5 transactions